Business
Axsome Therapeutics Presents New Data from MOMENTUM Phase 3 Trial with AXS-07 Demonstrating Rapid Onset of Action and Reduced Symptom Recurrence in the Acute Treatment of Migraine
Significantly faster time to pain relief as compared to rizatriptan
About this update from Axsome Therapeutics, Inc.
[{"type":"text","content":" Significantly faster time to pain relief as compared to rizatriptan (p","length":145,"tagName":"div"}]